| Abstrakt: |
A study conducted by the Chinese Academy of Medical Sciences aimed to identify quality markers (Q-markers) for Zhenyuan Capsule (ZYC), a Chinese patent medicine used to treat cardiovascular diseases. The researchers used various methods including chemical analysis, network pharmacology, molecular docking, and molecular dynamics simulations to identify potential Q-markers. They found that ginsenosides, specifically ginsenoside Re, showed promise as Q-markers for ZYC. This research provides valuable insights into the quality evaluation of herbal medicines. [Extracted from the article] |
